Evidence map›Paper›PMID 33300056›Full record

ArticleMolecular medicine reports2021

Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions

Peter Gál, Tomáš Vasilenko, Ivan Kováč, Matúš Čoma, Ján Jakubčo, Martina Jakubčová, Vlasta Peržeľová, Lukáš Urban, Michal Kolář, František Sabol and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Assessment ofBiomolecules · 2024
    Article
  3. Article
  4. Article
  5. Matricellular proteins in cutaneous wound healing.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. In vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Peter GálDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Tomáš VasilenkoDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Ivan KováčDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Matúš ČomaDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Ján JakubčoDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Martina JakubčováDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Vlasta PeržeľováDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Lukáš UrbanDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Michal KolářLaboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic.
František SabolDepartment of Heart Surgery, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Ján LuczyDepartment of Heart Surgery, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Martin NovotnýDepartment of Biomedical Research, East‑Slovak Institute of Cardiovascular Diseases, 040 66 Košice, Slovak Republic.
Jaroslav MajerníkDepartment of Medical Informatics, Faculty of Medicine, Pavol Jozef Šafárik University, 040 66 Košice, Slovak Republic.
Hans-Joachim GabiusInstitute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig‑Maximilian‑University, D‑80539 Munich, Germany.
Karel Jr SmetanaInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague.
Charles University · CZCzech Academy of Sciences · CZLudwig-Maximilians-Universität München · DEUniversity of Pavol Jozef Šafárik · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the molecular and cellular processes in skin wound healing can pave the way for devising innovative concepts by turning the identified natural effectors into therapeutic tools. Based on the concept of broad‑scale engagement of members of the family of galactoside‑binding lectins (galectins) in pathophysiological processes, such as cancer or tissue repair/regeneration, the present study investigated the potential of galectins‑1 (Gal‑1) and ‑3 (Gal‑3) in wound healing. Human dermal fibroblasts, which are key cells involved in skin wound healing, responded to galectin exposure (Gal‑1 at 300 or Gal‑3 at 600 ng/ml) with selective changes in gene expression among a panel of 84 wound‑healing‑related genes, as well as remodeling of the extracellular matrix. In the case of Gal‑3, positive expression of Ki67 and cell number increased when using a decellularized matrix produced by Gal‑3‑treated fibroblasts as substrate for culture of interfollicular keratinocytes.

Indexed as

Gene Expression RegulationTensile StrengthBlood ProteinsCollagenDermisFibroblastsGalectinsHumansWounds and InjuriesBlood ProteinsCollagenGalectinsLGALS3 protein, humanextracellular matrixfibroblastkeratinocytelectinregeneration

Identifiers

PMID33300056
PMCPMC7723164
OpenAlexW3109302564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.